S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GSK plc stock logo
GSK
GSK
$39.60
-0.9%
$41.99
$33.33
$43.84
$82.79B0.642.75 million shs2.77 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$103.44
-0.3%
$100.19
$62.55
$144.93
$39.74B1.623.22 million shs2.00 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.41
-1.1%
$27.19
$25.26
$41.33
$145.47B0.6133.46 million shs43.79 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GSK plc stock logo
GSK
GSK
-0.86%-2.67%-6.05%+0.15%+7.67%
Moderna, Inc. stock logo
MRNA
Moderna
-0.34%-3.45%-0.79%+4.41%-27.48%
Pfizer Inc. stock logo
PFE
Pfizer
-1.11%-3.42%-8.42%-9.56%-37.35%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GSK plc stock logo
GSK
GSK
2.6179 of 5 stars
0.03.03.30.02.60.02.5
Moderna, Inc. stock logo
MRNA
Moderna
3.8494 of 5 stars
3.12.00.04.61.73.30.6
Pfizer Inc. stock logo
PFE
Pfizer
4.9926 of 5 stars
3.25.04.24.83.11.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GSK plc stock logo
GSK
GSK
2.40
HoldN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
2.24
Hold$126.4922.28% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.35
Hold$36.8845.15% Upside

Current Analyst Ratings

Latest GSK, PFE, and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
Moderna, Inc. stock logo
MRNA
Moderna
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/9/2024
Moderna, Inc. stock logo
MRNA
Moderna
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$125.00
4/1/2024
Moderna, Inc. stock logo
MRNA
Moderna
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
3/28/2024
Moderna, Inc. stock logo
MRNA
Moderna
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$125.00
3/28/2024
Moderna, Inc. stock logo
MRNA
Moderna
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/22/2024
Pfizer Inc. stock logo
PFE
Pfizer
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/4/2024
GSK plc stock logo
GSK
GSK
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
2/26/2024
Moderna, Inc. stock logo
MRNA
Moderna
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Reduce$75.00 ➝ $86.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GSK plc stock logo
GSK
GSK
$37.71B2.18$5.14 per share7.71$7.74 per share5.12
Moderna, Inc. stock logo
MRNA
Moderna
$6.85B5.78N/AN/A$36.33 per share2.85
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.46$2.94 per share8.63$15.81 per share1.61

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GSK plc stock logo
GSK
GSK
$6.13B$3.0113.168.921.8316.24%51.45%10.57%5/1/2024 (Confirmed)
Moderna, Inc. stock logo
MRNA
Moderna
-$4.71B-$12.41N/AN/AN/A-68.84%-10.23%-7.70%5/2/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.579.171.163.62%10.88%4.91%5/1/2024 (Confirmed)

Latest GSK, PFE, and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
GSK plc stock logo
GSK
GSK
$0.95N/A-$0.95N/AN/AN/A
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
2/22/2024Q4 2023
Moderna, Inc. stock logo
MRNA
Moderna
-$0.78$0.55+$1.33$0.55$2.53 billion$2.80 billion    
1/31/2024Q4 2023
GSK plc stock logo
GSK
GSK
$0.76$0.72-$0.04$1.23$9.79 billion$10.00 billion
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GSK plc stock logo
GSK
GSK
$1.594.02%-18.20%52.82%1 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.61%+2.57%466.67%15 Years

Latest GSK, PFE, and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
GSK plc stock logo
GSK
GSK
quarterly$0.35643.4%2/22/20242/23/20244/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GSK plc stock logo
GSK
GSK
1.19
0.88
0.62
Moderna, Inc. stock logo
MRNA
Moderna
0.04
3.42
3.36
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
GSK plc stock logo
GSK
GSK
15.74%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
GSK plc stock logo
GSK
GSK
10.00%
Moderna, Inc. stock logo
MRNA
Moderna
15.70%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
GSK plc stock logo
GSK
GSK
70,2002.07 billion1.87 billionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
5,600382.88 million322.77 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

GSK, PFE, and MRNA Headlines

SourceHeadline
The 3 Most Overlooked Stocks Set for a Triple-Digit ComebackThe 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
investorplace.com - April 17 at 5:48 PM
Pfizer-Connect Biopharma deal for anti-inflammatory agent endsPfizer-Connect Biopharma deal for anti-inflammatory agent ends
msn.com - April 17 at 2:42 PM
Pfizer Inc. (NYSE:PFE) Shares Acquired by KLCM Advisors Inc.Pfizer Inc. (NYSE:PFE) Shares Acquired by KLCM Advisors Inc.
marketbeat.com - April 17 at 1:39 PM
Pfizer (NYSE:PFE) Trading Down 0.8%Pfizer (NYSE:PFE) Trading Down 0.8%
marketbeat.com - April 17 at 12:42 PM
Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pactConnect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact
fiercebiotech.com - April 17 at 9:42 AM
Pfizers academic-partnered R&D unit is scrapped as part of cost-cutting measuresPfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
fiercebiotech.com - April 17 at 9:42 AM
HealthInvest Partners AB Acquires Shares of 42,820 Pfizer Inc. (NYSE:PFE)HealthInvest Partners AB Acquires Shares of 42,820 Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 16 at 6:50 PM
Pfizers Doldrums, Just A Bad Case Of COVID-19?Pfizer's Doldrums, Just A Bad Case Of COVID-19?
seekingalpha.com - April 16 at 2:34 PM
Pfizer (NYSE:PFE) Stock Price Down 0.2%Pfizer (NYSE:PFE) Stock Price Down 0.2%
marketbeat.com - April 16 at 2:02 PM
Pfizers (PFE) Overweight Rating Reaffirmed at Cantor FitzgeraldPfizer's (PFE) Overweight Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - April 16 at 4:26 AM
Why the Market Dipped But Pfizer (PFE) Gained TodayWhy the Market Dipped But Pfizer (PFE) Gained Today
zacks.com - April 15 at 6:51 PM
Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A TalkPfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk
seekingalpha.com - April 15 at 5:39 PM
Pfizer (NYSE:PFE) Trading Up 0.7%Pfizer (NYSE:PFE) Trading Up 0.7%
marketbeat.com - April 15 at 3:37 PM
A Closer Look at Pfizers Options Market DynamicsA Closer Look at Pfizer's Options Market Dynamics
benzinga.com - April 15 at 12:38 PM
Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 15 at 11:27 AM
Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)
marketbeat.com - April 15 at 11:21 AM
Is Pfizer Stock a Buy?Is Pfizer Stock a Buy?
fool.com - April 15 at 8:45 AM
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis marketPfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
biopharma-reporter.com - April 15 at 7:37 AM
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
fool.com - April 15 at 4:53 AM
Conning Inc. Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)Conning Inc. Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 14 at 3:45 PM
Lecap Asset Management Ltd. Invests $1.32 Million in Pfizer Inc. (NYSE:PFE)Lecap Asset Management Ltd. Invests $1.32 Million in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 13 at 8:17 PM
Pfizer wins pause on Modernas COVID-19 patent lawsuitPfizer wins pause on Moderna's COVID-19 patent lawsuit
reuters.com - April 13 at 7:22 PM
The Smartest Dividend Stocks to Buy With $400 Right NowThe Smartest Dividend Stocks to Buy With $400 Right Now
fool.com - April 13 at 5:47 AM
Pfizer Inc. (NYSE:PFE) to Post Q1 2025 Earnings of $0.59 Per Share, Zacks Research ForecastsPfizer Inc. (NYSE:PFE) to Post Q1 2025 Earnings of $0.59 Per Share, Zacks Research Forecasts
americanbankingnews.com - April 13 at 3:08 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

GSK logo

GSK

NYSE:GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Moderna logo

Moderna

NASDAQ:MRNA
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.